Doug Schenkel
Stock Analyst at Wolfe Research
(3.45)
# 956
Out of 5,081 analysts
68
Total ratings
36.67%
Success rate
46.01%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Upgrades: Outperform | $75 | $105.96 | -29.22% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $27.24 | +17.47% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $74.91 | -19.90% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $75.00 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $31.17 | +92.49% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $23.36 | +19.86% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $284.31 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $166.52 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $3.51 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $228.46 | +24.75% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $47.86 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $149.26 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $46.82 | +10.00% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $17.87 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $127.95 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.25 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $580.45 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.33 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $103.26 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $2.43 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.29 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $238.21 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $397.62 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.92 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.29 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.08 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.22 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.89 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.75 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.69 | +965.09% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $19.93 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $307.56 | -70.74% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $7.48 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $191.10 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $64.85 | -75.33% | 2 | Sep 28, 2017 |
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $105.96
Upside: -29.22%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $27.24
Upside: +17.47%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $74.91
Upside: -19.90%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $75.00
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $31.17
Upside: +92.49%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $23.36
Upside: +19.86%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $284.31
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $166.52
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.51
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $228.46
Upside: +24.75%
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $47.86
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $149.26
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $46.82
Upside: +10.00%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $17.87
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $127.95
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $101.25
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $580.45
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $7.33
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $103.26
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $2.43
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.29
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $238.21
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $397.62
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.92
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.29
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.08
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.22
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.89
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $22.75
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.69
Upside: +965.09%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $19.93
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $307.56
Upside: -70.74%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $7.48
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $191.10
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $64.85
Upside: -75.33%